Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 7.68% | 161.38 | 0.0% | $1898.51m | |
| OCGN | Ocugen, Inc. | 6.32% | 8.75 | 0.0% | $1079.84m | |
| BNTX | BioNTech SE | 6.63% | 192.77 | 0.0% | $872.52m | |
| AMGN | Amgen, Inc. | 0.43% | 251.38 | 1.3% | $740.91m | |
| NVAX | Novavax, Inc. | 8.84% | 131.69 | 79.8% | $572.50m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 0.26% | 7.68 | 0.7% | $536.86m | |
| GILD | Gilead Sciences, Inc. | -0.55% | 68.53 | 1.0% | $504.56m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.11% | 516.62 | 2.7% | $432.65m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.09% | 173.49 | 2.0% | $412.31m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 1.28% | 217.09 | 1.9% | $311.54m | |
| ILMN | Illumina, Inc. | 2.03% | 381.03 | 3.5% | $302.74m | |
| BIIB | Biogen, Inc. | -0.53% | 280.21 | 1.7% | $269.43m | |
| VXRT | Vaxart, Inc. | 4.92% | 6.61 | 0.0% | $240.79m | |
| CRSP | CRISPR Therapeutics AG | 5.58% | 106.64 | 0.6% | $171.41m | |
| BNGO | Bionano Genomics, Inc. | 22.45% | 5.40 | 0.0% | $162.77m |
Company Profile
Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development and commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. The firm products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA.